Sapio AI capabilities simplify scientists’ work by leveraging large language models (LLM) to create experiments, query product documentation, search and visualize instrument and scientific data, and generate Python code. BALTIMORE- Sapio Sciences, the science-awareTM lab informatics platform, today announced that it has beta-launched breakthrough scientific features by integrating large language models (LLM) into its unified [...]

VANCOUVER, B.C. and PRINCETON, NJ -- Xybion Digital Inc. (TSXV: XYBN) (“Xybion” or the “Company“) is pleased to announce the closing of an acquisition (the “Acquisition”) of all of the issued and outstanding shares in the capital of Autoscribe Limited (“Autoscribe”) pursuant to a share purchase agreement among the Company, Autoscribe and all of the [...]

Company names Jonathan Eads as VP of Engineering and Promotes Brittnee Jones to VP of Product Management and Customer Success Genomenon, a leading Genomic Intelligence company, today announced two appointments within its executive team, further strengthening its commitment to delivering leading-edge precision medicine technologies. Jonathan Eads has joined the company as Vice President of Engineering, [...]

We are delighted to announce SLS is now a proud partner of LGC Standards. Through this collaboration, we now proudly feature over 20,000 products from esteemed brands such as Dr Ehrenstorfer, LGC Mikromol™, Paragon Scientific, and VHG in our portfolio. This partnership allows us to provide our customers with access to high-quality reference standards, further [...]

Partnership set to enhance CRO’s end-to-end clinical genomics services, advancing precision, collaboration, scalability, and alignment to CLIA quality standards Labbit LIMS by Semaphore Solutions set to take Eremid’s clinical genomics services to the next level in alignment with clinical quality standards. KANNAPOLIS, NC, USA –  Eremid® Genomic Services, LLC (“Eremid”) announces a strategic partnership with Semaphore Solutions, a leader in informatics [...]

Agreement grants rights to further develop an assay for pre-transplant prognostic testing. CARDIFF, U.K. -- Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced that it has signed an exclusive global licensing agreement with Thermo Fisher Scientific, the world leader in serving science, to further develop an assay for pre-transplant [...]

New tag technology is self-cleaving and traceless, helping drug developers and manufacturers obtain pure proteins without remaining tag residues. New affinity chromatography resin and tag combination is applicable from early research through to bioprocessing. Cytiva, a global leader in life sciences, introduces the innovative Cytiva Protein Select technology, designed to streamline and accelerate recombinant protein [...]

AMSBIO has announced a new range of customizable ELISA assay kits designed to enable experienced researchers to achieve reliable and reproducible assay results. With over 500 ELISA kits to choose from, the new range covers a wide variety of biological processes, targets, and sample types. Reagents such as matched antibody pairs and a micro-ELISA pre-plate have been carefully [...]

BRANFORD, Conn. -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it had entered into an agreement with Elta 90 to distribute Quantum-Si’s groundbreaking Platinum™ instrument and consumables in Southeast Europe as demand grows for the first of its kind next-generation protein sequencing™ platform. This agreement between Quantum-Si and ELTA 90 holds [...]

Research Triangle Park, NC – EpiCypher announces the development of a fully automated CUT&RUN assay (autoCUT&RUN) for high-throughput mapping of chromatin features. Based on EpiCypher’s industry-leading CUTANA® CUT&RUN kits, this technology is a significant paradigm shift in epigenomic profiling, enabling scaled research that will advance therapeutic development and biomarker discovery. CUT&RUN is a powerful approach [...]